Description

With the number of internationally-run clinical drug trials increasing, the double standards between those in developed nations and those in developing nations are being scrutinized under the ethical microscope. Many

With the number of internationally-run clinical drug trials increasing, the double standards between those in developed nations and those in developing nations are being scrutinized under the ethical microscope. Many argue that several pharmaceutical companies and researchers are exploiting developing nation participants. Two issues of concern are the use of a placebo control when an effective alternative treatment exists and the lack of drug availability to the country that hosted the clinical trial should the experimental drug prove effective.

Reuse Permissions
  • 739.4 KB application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2013
    Resource Type
  • Text
  • Collections this item is in
    Note
    • Partial requirement for: Ph. D., Arizona State University, 2013
      Note type
      thesis
    • Includes bibliographical references (p. 166-172)
      Note type
      bibliography
    • Field of study: Philosophy

    Citation and reuse

    Statement of Responsibility

    by Danielle Fundora

    Machine-readable links